GENERAL INTRODUCTION, AIM, OUTLINE OF THESIS 13 2.1.2 DNA damage: DNA adducts DNA adducts are a form of DNA damage caused by covalent binding between DNA and reactive (metabolites of) chemicals leading to the genetic damage if DNA adducts cannot be removed or repaired before the next round of the replication (Pottenger et al. 2019). Some of the DNA adducts can block the replication and induce DNA damage responses consisting of various DNA repair pathways, for instance, nucleotide excision repair (NER), base excision repair (BER), homologous recombination (HR) and nonhomologous DNA end joining (NHEJ), damage tolerance processes, and cell-cycle checkpoints (Giglia-Mari et al. 2011;Pottenger et al. 2019), which catalyse repair of the DNA modifications. Among these mechanisms, DNA damage tolerance processes contribute to survival after DNA damage and, in some situations, also actively promote the generation of mutations (Waters et al. 2009), for instance, translesion synthesis (TLS) polymerases mediate an error-prone process that tolerates chemical modifications of the bases and is able to replicate DNA directly in order to bypass template DNA damage, which induces a high probability of inserting an incorrect base. Other DNA adducts that do not block the replication are potentially more mutagenic and their mutation efficiency is chemical structure dependent (Pottenger et al. 2019). For instance, O 6 -alkyl/hydroxyalkylguanine (O 6 -alkylG) has been reported to show a high frequency of mispairing (80%) while N 7 -alkyl/hydroxyalkylguanine (N 7 -alkylG) shows a low frequency (below 0.1%), the first one resulting from the disruption of the possibility for hydrogen bond formation between O6 at guanine and H41 at cytosine thereby generating G to A transitions. If the mutation occurs in critical genes, for example those that suppress cancer development, such as the p53 gene, or in regions regulating transcription of oncogenes such as the k-ras gene (Hwa Yun et al. 2020), the mutation will increase the chances for further carcinogenic transformation.
Tumor developmentMutation is necessary but not sufficient for tumor formation (Poirier 2016). A tumor can be defined as a group of cells losing mechanisms for controlling their normal growth (Poirier 2012). This process can be initiated by exposure to chemicals that can damage or bind to the DNA, resulting in the permanent DNA mutations. During the exposure, cells can gradually, by subsequent mutations, develop the ability to sustain the proliferative signalling, evade growth suppressors, resist cell death, enable replicative immortality, induce angiogenesis, and activate invasion and metastasis (Hanahan and Weinberg 2011), accompanied by formation of abnormal proteins as well as distortion of chromosomal stability. Thus, the tumor formation is a multistep process that requires multiple mutations developing over a long period of time from the beginning of the chronic exposure to the appearance of the tumor (Poirier 2012).